ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenario.
Ecancermedicalscience
; 16: 1407, 2022.
Article
in En
| MEDLINE
| ID: mdl-36072236
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Ecancermedicalscience
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: